Long sleep linked to Alzheimer's protein marker in blood study

Researchers at UT Health San Antonio have found that people who regularly sleep more than eight and a half hours each night show higher levels of phosphorylated tau 181, or p-tau181, a protein marker associated with Alzheimer's disease that can now be measured in blood. The discovery emerged from analysis of 2,410 participants in the Framingham Heart Study, a long-running community health survey based in Massachusetts. The connection held even after accounting for age, sex, sleep apnea, depression, kidney function, and genetic variants known to increase Alzheimer's risk—suggesting the link between extended sleep and this particular protein may be genuine.

The relationship between sleep duration and p-tau181 levels was not straightforward. Rather than increasing steadily with every additional hour of sleep, the protein levels climbed most sharply once participants reported sleeping ten hours or more per night. This nonlinear pattern—where the strength of the association changes depending on where you fall on the sleep spectrum—proved crucial to the finding. Vanessa M. Young, a postdoctoral fellow at the Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases who led the work, explained that using traditional statistical methods that assume a simple, straight-line relationship would have obscured the pattern entirely. The team employed restricted cubic splines, a modeling technique designed to capture these kinds of curved, complex associations in data.

The study participants averaged 70 years old, with just over half being women. When researchers examined three other blood proteins linked to brain cell damage and neurodegeneration, the sleep association disappeared once kidney function was factored in. Only p-tau181 remained robustly connected to sleep duration, suggesting that the link might be specific to Alzheimer's-related processes rather than a general marker of brain aging. Young cautioned that because this analysis captured a single moment in time rather than following people over years, the findings cannot prove that long sleep causes Alzheimer's disease. Instead, she framed the results as a potential warning sign worth investigating further—evidence that more sleep does not automatically mean better brain health.

The work builds on a 2025 study by some of the same researchers showing that sleeping nine hours or more per night was associated with worse cognitive performance, particularly among people with depression. That earlier finding prompted the team to dig deeper, using more sophisticated statistical tools and examining blood-based biomarkers that reflect Alzheimer's pathology in the brain. The timing of this research reflects a broader shift in neuroscience: until recently, Alzheimer's biomarkers could only be detected through invasive procedures like spinal taps or expensive brain imaging. The emergence of blood tests that can identify these markers has opened new possibilities for studying how lifestyle factors relate to brain disease risk.

Alzheimer's disease accounts for 60 to 70 percent of the 57 million dementia cases worldwide, making it a profound public health challenge. Even with recent advances in disease-modifying drugs, identifying modifiable risk factors—behaviors or habits people can change—remains a critical research priority. Sleep is an appealing target because it is something people can theoretically control, unlike genetic predisposition. Yet the existing evidence on sleep and Alzheimer's has been mixed and incomplete, with some studies suggesting too little sleep is harmful and others pointing to risks from too much.

Young's recommendation to patients is practical and measured: if you find yourself regularly sleeping nine to ten hours or more each night, it may be worth discussing with your doctor as part of a broader conversation about sleep quality and brain health. She emphasized that this is not a reason to panic or to assume that long sleep will inevitably lead to cognitive decline. Rather, it is a signal that warrants attention and further investigation. The researchers concluded that long sleep should be considered a potential behavioral marker of elevated p-tau181, though they acknowledged that prospective studies—ones that follow people forward in time—will be needed to confirm whether the association reflects early neurodegeneration or some other process entirely. The work opens a new line of inquiry into how sleep patterns might serve as an early window into brain aging.